Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dimethyloxalylglycine preconditioning enhances protective effects of bone marrow-derived mesenchymal stem cells in Aβ- induced Alzheimer disease
Banafshe Esmaeilzade, Tayebe Artimani, Iraj Amiri, et al.
Physiology & Behavior (2018) Vol. 199, pp. 265-272
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Cells (2021) Vol. 10, Iss. 8, pp. 1884-1884
Open Access | Times Cited: 69
Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies
Mohammad Saeed Kahrizi, Elnaz Mousavi, Armin Khosravi, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
HIF-1α activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization
Meihua Chen, Yuhui Wang, Bingjing Sun, et al.
International Immunopharmacology (2021) Vol. 99, pp. 107901-107901
Open Access | Times Cited: 51
Translational insights into stem cell preconditioning: From molecular mechanisms to preclinical applications
Kasra Moeinabadi‐Bidgoli, Amirhesam Babajani, Ghasem Yazdanpanah, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112026-112026
Open Access | Times Cited: 48
Stem cell therapy for Alzheimer’s disease: An overview of experimental models and reality
Chuan Qin, Kewei Wang, Ling Zhang, et al.
Animal Models and Experimental Medicine (2022) Vol. 5, Iss. 1, pp. 15-26
Open Access | Times Cited: 31
Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicine
Maryam Adelipour, David M. Lubman, Jeongkwon Kim
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 6, pp. 491-507
Open Access | Times Cited: 19
Stem Cell Therapy for Alzheimer’s Disease: A Scoping Review for 2017–2022
Yunxiao Duan, Linshuoshuo Lyu, Siyan Zhan
Biomedicines (2023) Vol. 11, Iss. 1, pp. 120-120
Open Access | Times Cited: 17
The functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer’s disease: crosstalk between autophagy and apoptosis
Chuan Qin, Lin Bai, Yongning Li, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Genetic modification and preconditioning strategies to enhance functionality of mesenchymal stromal cells: a clinical perspective
Kasra Moeinabadi‐Bidgoli, Radman Mazloomnejad, Alireza Beheshti Maal, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 6, pp. 461-478
Closed Access | Times Cited: 16
Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer′s disease: progress, advantages, and challenges
RenataGuedes de Jesus Gonçalves, JulianaFerreira Vasques, AlmirJordão da Silva-Junior, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 8
Open Access | Times Cited: 21
Engrafted stem cell therapy for Alzheimer's disease: A promising treatment strategy with clinical outcome
Salwa, Lalit Kumar
Journal of Controlled Release (2021) Vol. 338, pp. 837-857
Closed Access | Times Cited: 24
Valproic acid preconditioning of bone marrow mesenchymal stem cells promotes remyelination of the corpus callosum in a cuprizone-induced demyelination model
Golaleh Noorzehi, Parichehr Pasbakhsh, Fatemeh Taghizadeh, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118027-118027
Closed Access
Essential oil ofSchisandra chinensisameliorates cognitive decline in mice by alleviating inflammation
Mengjie Xu, Xiaoying Zhang, Fangyi Ren, et al.
Food & Function (2019) Vol. 10, Iss. 9, pp. 5827-5842
Closed Access | Times Cited: 29
Extracellular vesicles isolated from mesenchymal stromal cells primed with neurotrophic factors and signaling modifiers as potential therapeutics for neurodegenerative diseases
Prajakta Teli, Vaijayanti Kale, Anuradha Vaidya
Current Research in Translational Medicine (2021) Vol. 69, Iss. 2, pp. 103286-103286
Closed Access | Times Cited: 23
Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation
Chuan Qin, Yongning Li, Kewei Wang
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 4761-4775
Open Access | Times Cited: 23
Preconditioning Methods to Improve Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Bone Regeneration—A Systematic Review
Fernanda Campos Hertel, Aline Silvestrini da Silva, Adriano de Paula Sabino, et al.
Biology (2022) Vol. 11, Iss. 5, pp. 733-733
Open Access | Times Cited: 16
Mesenchymal stem cell therapy for Alzheimer’s disease: A novel therapeutic approach for neurodegenerative diseases
Aditya Bhatt, Harshita Bhardwaj, Priyanka Srivastava
Neuroscience (2024) Vol. 555, pp. 52-68
Closed Access | Times Cited: 3
Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties
Giovanni Schepici, Agnese Gugliandolo, Emanuela Mazzon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2088-2088
Open Access | Times Cited: 12
Treadmill exercise enhances the promoting effects of preconditioned stem cells on memory and neurogenesis in Aβ-induced neurotoxicity in the rats
Rokhsareh Abshenas, Tayebe Artimani, ‬Siamak Shahidi, et al.
Life Sciences (2020) Vol. 249, pp. 117482-117482
Closed Access | Times Cited: 17
Administration of Selenium Nanoparticles Reverses Streptozotocin-Induced Neurotoxicity in the male rats
Bahareh Gholamigeravand, ‬Siamak Shahidi, Iraj Amiri, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 6, pp. 1259-1266
Closed Access | Times Cited: 15
Mesenchymal Stem Cells for Treating Alzheimer’s Disease: Cell Therapy and Chemical Reagent Pretreatment
Kexin Zhang, Xinzhe Du, Yao Gao, et al.
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 3, pp. 863-878
Closed Access | Times Cited: 6
Investigation of conditioned medium properties obtained from human umbilical cord mesenchymal stem/stromal cells preconditioned with dimethyloxalylglycine in a correlation with ultrastructural changes
Serbay Ozkan, Başak Işıldar, Serbay Özkan, et al.
Microscopy Research and Technique (2023) Vol. 87, Iss. 1, pp. 159-171
Open Access | Times Cited: 5
Restoring Synaptic Function: How Intranasal Delivery of 3D-Cultured hUSSC Exosomes Improve Learning and Memory Deficits in Alzheimer’s Disease
Masoumeh Pourhadi, Hakimeh Zali, Rasoul Ghasemi, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3724-3741
Closed Access | Times Cited: 5
RETRACTED: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer’s Disease
Xinxin Wang, Junwei Wu, Shanshan Ma, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 12
Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide
Hari Shanker Sharma, Dafin F. Mureșanu, Ala Nozari, et al.
Progress in brain research (2021), pp. e1-e2
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top